Mannkind Corp Stock Today
| MNKD Stock | USD 4.10 0.05 1.23% |
Performance7 of 100
| Odds Of DistressOver 69
|
MannKind Corp is trading at 4.10 as of the 19th of April 2024, a 1.23 percent up since the beginning of the trading day. The stock's lowest day price was 3.97. MannKind Corp has more than 69 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for MannKind Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 28th of July 2004 | Category Healthcare | Classification Health Care |
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. The company has 270.76 M outstanding shares of which 30.76 M shares are now shorted by private and institutional investors with about 6.85 trading days to cover. More on MannKind Corp
Moving against MannKind Stock
| 0.68 | LPTX | Leap Therapeutics Financial Report 20th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
MannKind Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. MannKind Corp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MannKind Corp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Founder and Executive Chairman | Alfred Mann | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Mannkind Corp | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, Dow Jones Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering MannKind Corp report their recommendations after researching MannKind Corp's financial statements, talking to executives and customers, or listening in on MannKind Corp's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering MannKind Corp. The MannKind consensus assessment is calculated by taking the average forecast from all of the analysts covering MannKind Corp. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of MannKind Corp's profitability, liquidity, and operating efficiency, MannKind Corp may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of MannKind Corp is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MannKind Corp's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to MannKind Corp's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand MannKind Corp's financial leverage. It provides some insight into what part of MannKind Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MannKind Corp (MNKD) is traded on NASDAQ Exchange in USA. It is located in 1 Casper Street, Danbury, CT, United States, 06810 and employs 411 people. MannKind Corp is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MannKind Corp's market, we take the total number of its shares issued and multiply it by MannKind Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MannKind Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 270.76 M outstanding shares of which 30.76 M shares are now shorted by private and institutional investors with about 6.85 trading days to cover.
MannKind Corp currently holds about 154.16 M in cash with 33.91 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Check MannKind Corp Probability Of Bankruptcy
Ownership AllocationMannKind Corp holds a total of 270.76 Million outstanding shares. Over half of MannKind Corp's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in MannKind Corp. Please watch out for any change in the institutional holdings of MannKind Corp as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check MannKind Ownership Details
MannKind Stock Price Odds Analysis
What are MannKind Corp's target price odds to finish over the current price? Based on a normal probability distribution, the odds of MannKind Corp jumping above the current price in 90 days from now is about 45.2%. The MannKind Corp probability density function shows the probability of MannKind Corp stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days MannKind Corp has a beta of -0.0491. This indicates as returns on the benchmark increase, returns on holding MannKind Corp are expected to decrease at a much lower rate. During a bear market, however, MannKind Corp is likely to outperform the market. Additionally, mannKind Corp has an alpha of 0.332, implying that it can generate a 0.33 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of MannKind Corp to move above the current price in 90 days from now is about 45.2 (This MannKind Corp probability density function shows the probability of MannKind Stock to fall within a particular range of prices over 90 days) .
MannKind Stock Institutional Holders
Institutional Holdings refers to the ownership stake in MannKind Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of MannKind Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing MannKind Corp's value.| Instituion | Recorded On | Shares | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 2.1 M | |
| Marshall Wace Asset Management Ltd | 2023-12-31 | 1.9 M | |
| Citadel Advisors Llc | 2023-09-30 | 1.8 M | |
| Amvescap Plc. | 2023-12-31 | 1.8 M | |
| 180 Wealth Advisors, Llc | 2023-12-31 | 1.7 M | |
| Emerald Advisers, Llc | 2023-12-31 | 1.2 M | |
| Ing Investment Management Llc | 2023-12-31 | 1.2 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.1 M | |
| Two Sigma Advisers, Llc | 2023-12-31 | 1.1 M | |
| Blackrock Inc | 2023-12-31 | 22.3 M | |
| Vanguard Group Inc | 2023-12-31 | 15.2 M |
MannKind Corp Historical Income Statement
MannKind Corp Income Statement is one of the three primary financial statements used for reporting MannKind's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of MannKind Corp revenue and expense. MannKind Corp Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, MannKind Corp's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 208.9 M, whereas Total Operating Expenses is forecasted to decline to about 109.2 M. View More FundamentalsMannKind Stock Against Markets
Picking the right benchmark for MannKind Corp stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in MannKind Corp stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for MannKind Corp is critical whether you are bullish or bearish towards MannKind Corp at a given time. Please also check how MannKind Corp's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in MannKind Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
MannKind Corp Corporate Directors
MannKind Corp corporate directors refer to members of a MannKind Corp board of directors. The board of directors generally takes responsibility for the MannKind Corp's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of MannKind Corp's board members must vote for the resolution. The MannKind Corp board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Michael Friedman | Independent Director | Profile | |
| Ronald Consiglio | Independent Director | Profile | |
| David MacCallum | Independent Director | Profile | |
| Kent Kresa | Lead Independent Director | Profile |
How to buy MannKind Stock?
Before investing in MannKind Corp, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in MannKind Corp. To buy MannKind Corp stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of MannKind Corp. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase MannKind Corp stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located MannKind Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased MannKind Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as MannKind Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy MannKind Stock please use our How to Invest in MannKind Corp guide.
Already Invested in MannKind Corp?
The danger of trading MannKind Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of MannKind Corp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than MannKind Corp. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile MannKind Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether MannKind Corp is a strong investment it is important to analyze MannKind Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MannKind Corp's future performance. For an informed investment choice regarding MannKind Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MannKind Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For information on how to trade MannKind Stock refer to our How to Trade MannKind Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for MannKind Stock analysis
When running MannKind Corp's price analysis, check to measure MannKind Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MannKind Corp is operating at the current time. Most of MannKind Corp's value examination focuses on studying past and present price action to predict the probability of MannKind Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MannKind Corp's price. Additionally, you may evaluate how the addition of MannKind Corp to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is MannKind Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MannKind Corp. If investors know MannKind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MannKind Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share 0.745 | Quarterly Revenue Growth 0.622 | Return On Assets 0.0172 |
The market value of MannKind Corp is measured differently than its book value, which is the value of MannKind that is recorded on the company's balance sheet. Investors also form their own opinion of MannKind Corp's value that differs from its market value or its book value, called intrinsic value, which is MannKind Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MannKind Corp's market value can be influenced by many factors that don't directly affect MannKind Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MannKind Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if MannKind Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MannKind Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.